Legal NewsRoom
Menu

Menu

  • LEGAL NEWS
    HOT TOPICS
    • LexisNexis® Legal Newsroom
    • ACA and Healthcare Reform
    • Antitrust and Unfair Competition
    • Banking and Finance
    • Bankruptcy
    • California
    • Climate Change
    • Constitutional Law and Civil Rights
    • Consumer Protection & Privacy
    • Contracts and Commercial Law
    • Corporate
    • Criminal Law and Procedure
    • Energy
    • Environmental
    • Estate and Elder Law
    • Family Law
    • Financial Fraud Law
    • Florida
    • Fracking and Alternative Energy
    • Health Care
    • Hot Topics
    • Hurricane Sandy
    • Illinois
    • Immigration Law
    • Immigration Reform
    • Insurance Law
    • Intellectual Property
    • International Law
    • International Trade
    • Labor and Employment Law
    • Law360
    • Legal Business
    • Lexis® Hub
    • Litigation
    • Mealeys
    • Media and Entertainment
    • Mergers and Acquisitions
    • New Jersey
    • New York
    • Pennsylvania
    • Public Contracts
    • Public media
    • Public Policy
    • Real Estate Law
    • Securities
    • Sports Law
    • Tax Law
    • Technology
    • Texas
    • Top Emerging Trends
    • Torts
    • Virtual Currency
    • Workers' Compensation
  • NEWS & INSIGHT
    Blogs and Newsletters
      • BIZ Blog
      • Blog Mosaic
      • Business of Law Blog
      • Corporate Law Advisory
      • Legal Content Insider
      • LexTalk
      • State Net® Capitol Journal
    News & Trending Topics
        • Law360
        • Legal Insights & Trends
        • Lexis Practice Advisor Journal
    Professional Communities
      • Business Insight Solutions – Partner Portal
      • Corporate InfoPro (Corporate Information Professionals)
      • InfoPro (Legal Information Professionals)
      • LexisNexis® for Developers
      • Litigators Verdict & Settlement Exchange
VISIT LEXISNEXIS LEGAL & PROFESSIONAL
Search

Search

Please enter a Keyword
Sign In

Browse By Tags

  • Barr Laboratories Inc.
  • hormone replacement therapy
  • HRT
  • In re: Prempro Products Liability Litigation
  • Judge William R. Wilson Jr.
  • Jurisdiction
  • lawsuit
  • Litigation
  • MDL
  • Mead Johnson & Co.
  • multidistrict litigation
  • nondiverse defendants
  • Novartis Pharmaceuticals Corp.
  • personal injury
  • Prempro
  • Solvay Pharmaceuticals Inc.
  • torts
  • U.S. Supreme Court
  • Watson Laboratories Inc.
  • Wyeth
  • Wyeth v. Sandra Kirkland
  • Tom Moylan
    Tom Moylan
    • over 12 years ago
    • Litigation
    • Litigation Blog

    Supreme Court Won't Take Up Egregious Fraudulent Misjoinder In Hormone Cases

    WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on Oct. 12 denied review of a circuit court ruling that 112 hormone replacement therapy (HRT) plaintiffs did not fraudulently misjoin nondiverse defendants in order to keep their cases in Minnesota...
United States
Copyright © LexisNexis
  • Argentina
  • Canada
  • Chile
  • Columbia
  • Mexico
  • United States
  • Latin America and the Caribbean
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hong Kong
  • United Kingdom
  • Israel
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • International Sales(Includes Middle East)
  • Australia
  • China
  • India
  • Japan
  • Korea
  • Malaysia
  • New Zealand
  • Philippines
  • Russia
  • Singapore
  • Taiwan

Company

  • About Us
  • Leadership
  • Press Room
  • Rule of Law
  • Responsibility
  • Careers
  • Partners/Alliances

Top Product Pages

  • Lexis Advance®
  • Lexis® Practice Advisor
  • Law Schools
  • LexisNexis® CourtLink
  • nexis.com®

Product sign-in

  • Sign-In Index Page
  • Lexis Advance®
  • Lexis® Practice Advisor
  • Law Schools
  • nexis.com®

Quick Links

  • LexisNexis
  • Legal & Professional Solutions
  • Risk Solutions
  • Product Index
  • Site Map

Policies

  • Privacy Information
  • Terms & Conditions
  • Cookie Policy

Follow us

  • LinkedIn
  • YouTube
  • Facebook
  • Twitter
  • Subscribe